Novel urine-based test offers new hope for bladder cancer patients

Bladder cancer, notorious for being one of the most costly malignancies to manage, often results in patient discomfort and frequent invasive and expensive procedures. Traditional treatments, though gradually being replaced by immune checkpoint inhibitors (ICIs), have yielded varied success rates with limited predictors for individual patient responses.